The Insulin-Only Bionic Pancreas Pivotal Trial

The Insulin-Only Bionic Pancreas Pivotal Trial

Conditions: Diabetes Mellitus; Type 1 Diabetes; Diabetes Mellitus, Type 1
Interventions: Combination Product: Bionic Pancreas (BP) with Aspart or Lispro; Combination Product: Bionic Pancreas with Fiasp (BPFiasp); Other: Usual Care (UC); Other: BP Guidance Insulin Dosing
Sponsors: Jaeb Center for Health Research; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Beta Bionics, Inc.; Boston University; Massachusetts General Hospital
Completed

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

November 8, 2023Comments OffClinicalTrials.gov | Endocrinology Clinical Trials | Endocrinology Studies | US National Library of Medicine
Comments